LORI DUPERE: Open Payments
NPI 1861035453 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,481 in 55 payments from 21 companies in 2025. Trend: 2023 $2,532 · 2024 $4,434 · 2025 $1,481
Food & beverage: $1,220Consulting: $150Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $200 |
| Otsuka America Pharmaceutical, Inc. | 8 | $164 |
| SK Life Science, Inc. | 6 | $152 |
| JAZZ PHARMACEUTICALS INC. | 1 | $150 |
| ABBVIE INC. | 4 | $114 |
| E.R. Squibb & Sons, L.L.C. | 1 | $109 |
| PFIZER INC. | 3 | $68 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| C2N Diagnostics, LLC | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $57 |
Products named: REXULTI, XYWAV, ZEPOSIA, XCOPRI, AUSTEDO XR, VRAYLAR, NURTEC ODT, PRECIVITYAD2.
Industry payments across FL — which companies pay providers there.
